Chicago Atlantic BDC Inc(LIEN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 6.56 | EPS (ttm) | 1.39 | Insider Own | 14.81% | Shs Outstand | 22.8M | Perf Week | -0.11% |
| Market Cap | 0.21B | Forward P/E | 5.52 | EPS next Y | 10% | Insider Trans | 3.94% | Shs Float | 19.4M | Perf Month | -4.11% |
| Enterprise Value | 0.23B | PEG | 0.94 | EPS next Q | 0.38 | Inst Own | 11.87% | Short Float | 0.46% | Perf Quarter | -2.46% |
| Income | 0.03B | P/S | 3.47 | EPS this Y | 3.45% | Inst Trans | - | Short Ratio | 1.45 | Perf Half Y | -2.36% |
| Sales | 0.06B | P/B | 0.69 | EPS next 5Y | 5.86% | ROA | 9.38% | Short Interest | 0.09M | Perf YTD | -11.81% |
| Book/sh | 13.26 | P/C | 223.54 | EPS past 3/5Y | - | ROE | 10.48% | 52W High | -19.17% ($11.27) | Perf Year | -10.82% |
| Cash/sh | 0.04 | P/FCF | 10.23 | Sales past 3/5Y | 1653.42% - | ROIC | 9.61% | 52W Low | 2.13% ($8.92) | Perf 3Y | 2.67% |
| Dividend Est. | $1.36 (14.93%) | EV/EBITDA | 6.78 | EPS Y/Y TTM | 34.42% | Gross Margin | 74.91% | Volatility(W/M) | 1.68% 2.22% | Perf 5Y | - |
| Dividend TTM | 1.36 | EV/Sales | 3.9 | Sales Y/Y TTM | 47.16% | Oper. Margin | 57.54% | ATR (14) | 0.19 | Perf 10Y | - |
| Dividend Ex-Date | 2026/9/25 | Quick Ratio | 0.45 | EPS Q/Q | -29.37% | Profit Margin | 52.82% | RSI (14) | 37.43 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.45 | Sales Q/Q | 6.81% | SMA20 | -0.44% ($9.15) | Beta | 0.29 | Target Price | $11 |
| Payout | 93.26% | Debt/Eq | 0.09 | Earnings | 2026/11/12 | SMA50 | -6.2% ($9.71) | Rel Volume | 1.23 | Prev Close | $9.12 |
| Employees | - | LT Debt/Eq | 0.09 | EPS/Sales Surpr. | -15% -13.91% | SMA200 | -6.8% ($9.77) | Avg Volume(3M) | 0.06M | Price | $9.11 |
| IPO | 2022/2/4 | Option/Short | No/Yes | Trades | 311 | Volume | 75,812 | Change | -0.11% |
🌿 Chicago Atlantic BDC (ticker: LIEN) is a business development company (BDC) that focuses primarily on the U.S. cannabis industry. It provides senior secured loans to state-legal cannabis operators and niche borrowers that traditional financial institutions tend to avoid, and it operates as part of the Chicago Atlantic credit platform.
Over the past 1 year, on the lower side
19% below its 1-year high.
Traded about as much as usual. That is 123% of its average volume.
Next earnings report: November 12
9 days to go.
Company yardsticks do not fit here, so profitability, valuation and earnings are left out. The other verdicts still apply.
Growth is moderate
Earnings are expected to grow by +3.5% this year.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are roughly flat
Bought 3 years ago, your return today would be +2.7%.
Tap to view numbers
Dividends are paid consistently
Pays 14.93% annually in dividends.
Tap to view numbers
Ownership is about average
Institutions hold 11.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
CNBS Amplify Seymour Cannabis ETF <0.01% It ranks #91 of 137 in the industry
Based on market cap of $208M.
CYPH#88 Cypherpunk Technologies Inc $254M PER 4.2 
IVAI#89 Ives Ultra AI Opportunities Inc $253M PER - LIEN#91 Chicago Atlantic BDC Inc $208M PER 6.6 
WHG#96 Westwood Holdings Group Inc $177M PER 21.4 
WHF#97 WhiteHorse Finance Inc $174M PER 10.2 
FAQ
What kind of company is LIEN?
LIEN belongs to the Financial sector and operates in the Asset Management industry.
What is the market cap of LIEN?
The market cap of LIEN is approximately $208M, ranking 3,970 within its sector.
Does LIEN pay dividends?
LIEN has a dividend yield of approximately 14.93%, with an annual dividend of $1.36.
What is the P/E ratio of LIEN?
LIEN has a P/E ratio of approximately 6.6x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for LIEN?
LIEN has recorded a 52-week high of $11.27 and a low of $8.92.
